Biotechnology Amicus Therapeutics Receives Positive CHMP Opinion for Pombiliti(TM) (cipaglucosidase alfa) for Late-Onset Pompe Disease December 16, 2022
Biotechnology Apellis Submits Marketing Authorization Application to the European Medicines Agency for Pegcetacoplan for Geographic Atrophy December 16, 2022
Health Gilead Sciences: Latinas Contra Cancer Empowers Patients To Advocate for Change December 15, 2022
Search
Health
